Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors

Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) exploit the concept of synthetic lethality and offer great promise in the treatment of tumors with deficiencies in homologous recombination (HR) repair. PARPi exert antitumor activity by blocking Poly(ADP-ribosyl)ation (PARylation) and trapping...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Yu-Yi, Yam, Clinton, Yamaguchi, Hirohito, Hung, Mien-Chie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594904/
https://www.ncbi.nlm.nih.gov/pubmed/36284291
http://dx.doi.org/10.1186/s12929-022-00870-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594904/
https://www.ncbi.nlm.nih.gov/pubmed/36284291
http://dx.doi.org/10.1186/s12929-022-00870-7

Ejemplares similares